Constantinos E. Alifieris
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Oncology 5
- Cancer Immunotherapy and Biomarkers 2
- CAR-T cell therapy research 1
-
- Breast Cancer Treatment Studies 2
- Cancer Genomics and Diagnostics 1
- Carcinogens and Genotoxicity Assessment 1
- Co-authors
- Dimitrios T. Trafalis (14 shared papers)Anastasia Constantinidou (1 shared paper)George D. Geromichalos (2 shared papers)Nikolaos M. Sitaras (4 shared papers)George P. Stathopoulos (3 shared papers)Chrysovalantis Vergadis (1 shared paper)Sébastien Sauvage (1 shared paper)Dimitrios Krikelis (2 shared papers)
- Journals
- Pharmacology & Therapeutics (2 papers)Biomedicines (2 papers)Anti-Cancer Drugs (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)Journal of Immunotherapy (1 paper)
- Partner nations
- GreeceCyprusUnited States
In The Last Decade
Constantinos E. Alifieris
13 papers receiving 1.1k citations
Constantinos E. Alifieris's Hit Papers
Peers
Comparison fields: 5 of 94
- Genetics 195
- Cancer Research 167
- Oncology 280
- Biomaterials 102
- Immunology 151
Countries citing papers authored by Constantinos E. Alifieris
This map shows the geographic impact of Constantinos E. Alifieris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constantinos E. Alifieris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constantinos E. Alifieris more than expected).
Fields of papers citing papers by Constantinos E. Alifieris
This network shows the impact of papers produced by Constantinos E. Alifieris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constantinos E. Alifieris. The network helps show where Constantinos E. Alifieris may publish in the future.
Co-authors
The 20 scholars most cited alongside Constantinos E. Alifieris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Glioblastoma multiforme: Pathogenesis and treatment Hit paper breakdown → | 2015 | 646 |
| 2 | 2018 | 279 | |
| 3 | 2018 | 37 | |
| 4 | 2018 | 29 | |
| 5 | Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I. | 2017 | 27 |
| 6 | 2016 | 20 | |
| 7 | 2020 | 12 | |
| 8 | 2024 | 9 | |
| 9 | 2012 | 5 | |
| 10 | 2021 | 4 | |
| 11 | 2012 | 3 | |
| 12 | 2017 | 3 | |
| 13 | 2017 | 2 | |
| 14 | 2025 | 0 | |
| 15 | The arbitrary magic of p<0.05: Beyond statistics. | 2021 | 0 |
About Constantinos E. Alifieris
Constantinos E. Alifieris is a scholar working on Oncology, Cancer Research, Immunology, Molecular Biology and Statistics, Probability and Uncertainty, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (2 papers), Breast Cancer Treatment Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Mechanisms and Therapy (1 paper), Cancer Genomics and Diagnostics (1 paper), CAR-T cell therapy research (1 paper), Carcinogens and Genotoxicity Assessment (1 paper) and Meta-analysis and systematic reviews (1 paper). The work is most often cited by research in Genetics (195 citations), Cancer Research (167 citations), Oncology (280 citations), Biomaterials (102 citations) and Immunology (151 citations). Constantinos E. Alifieris has collaborated with scholars based in Greece, Cyprus and United States. Frequent co-authors include Dimitrios T. Trafalis, Anastasia Constantinidou, George D. Geromichalos, Nikolaos M. Sitaras, George P. Stathopoulos, Chrysovalantis Vergadis, Sébastien Sauvage, Dimitrios Krikelis, Athanasios Tampakis and Michalis Kontos. Their work appears in journals such as Pharmacology & Therapeutics, Biomedicines, Anti-Cancer Drugs, Cancer Chemotherapy and Pharmacology and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.